REFRACTORY OVARIAN CARCINOMA

Clinical trials for REFRACTORY OVARIAN CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY OVARIAN CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New cancer drug cocktail aims to shrink tough tumors

Disease control Terminated

This early-phase trial is testing the safety and best dose of a new oral drug, ZEN003694, when given with standard immunotherapy drugs (nivolumab with or without ipilimumab) for people with advanced solid tumors that have stopped responding to other treatments. The goal is to see…

Matched conditions: REFRACTORY OVARIAN CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY OVARIAN CARCINOMA

Get alerted when new REFRACTORY OVARIAN CARCINOMA trials appear

New cancer drug cocktail aims to shrink tough tumors